SYNTHETIC MULTIMERIC PEPTIDES DERIVED FROM THE V3-LOOP OF HIV-1 GP120 BIND TO GALCER AND BLOCK HIV-1 INFECTION IN CD4-NEGATIVE MUCOSAL EPITHELIAL-CELLS

被引：0
|
作者：
YAHI, N
SABATIER, JM
BAGHDIGUIAN, S
GONZALEZSCARANO, F
机构：
[1] FAC MED NORD,CNRS,URA 1455,MARSEILLE,FRANCE
[2] UNIV MONTPELLIER 2,INRA,CNRS,URA 1184,F-34060 MONTPELLIER,FRANCE
[3] UNIV PENN,DEPT NEUROL,PHILADELPHIA,PA 19104
来源：
JOURNAL OF CELLULAR BIOCHEMISTRY | 1995年
关键词：
D O I：
暂无
中图分类号：
Q5 [生物化学]; Q7 [分子生物学];
学科分类号：
071010 ; 081704 ;
摘要：
引用
收藏
页码：246 / 246
页数：1
相关论文
共 50 条
  • [1] SYNTHETIC MULTIMERIC PEPTIDES DERIVED FROM THE PRINCIPAL NEUTRALIZATION DOMAIN (V3 LOOP) OF HUMAN-IMMUNODEFICIENCY-VIRUS TYPE-1 (HIV-1) GP120 BIND TO GALACTOSYLCERAMIDE AND BLOCK HIV-1 INFECTION IN A HUMAN CD4-NEGATIVE MUCOSAL EPITHELIAL-CELL LINE
    YAHI, N
    SABATIER, JM
    BAGHDIGUIAN, S
    GONZALEZSCARANO, F
    FANTINI, J
    JOURNAL OF VIROLOGY, 1995, 69 (01) : 320 - 325
  • [2] IMMUNOGENICITY OF SYNTHETIC HIV-1 GP120 V3-LOOP PEPTIDE-CONJUGATE IMMUNOGENS
    CONLEY, AJ
    CONARD, P
    BONDY, S
    DOLAN, CA
    HANNAH, J
    LEANZA, WJ
    MARBURG, S
    RIVETNA, M
    RUSIECKI, VK
    SUGG, EE
    VANMIDDLESWORTH, F
    WARNE, SA
    ULRICH, JT
    RUDBACH, JA
    TOLMAN, RL
    EMINI, EA
    VACCINE, 1994, 12 (05) : 445 - 451
  • [3] STRUCTURAL STUDIES ON SYNTHETIC PEPTIDES FROM THE PRINCIPAL NEUTRALIZING DOMAIN OF HIV-1 GP120 THAT BIND TO CD4 AND ENHANCE HIV-1 INFECTION
    DETTIN, M
    DEROSSI, A
    AUTIERO, M
    GUARDIOLA, J
    CHIECOBIANCHI, L
    DIBELLO, C
    BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 1993, 191 (02) : 364 - 370
  • [4] Suramin: A polysulfonated compound that inhibits the binding of HIV-1 gp120 to GalCer/sulfatide and blocks the CD4-independent pathway of HIV-1 infection in mucosal epithelial cells
    Hammache, D
    Delezay, O
    Fantini, J
    Yahi, N
    PERSPECTIVES IN DRUG DISCOVERY AND DESIGN, 1996, 5 : 225 - 233
  • [5] CD4-DERIVED SYNTHETIC PEPTIDE BLOCKS THE BINDING OF HIV-1 GP120 TO CD4-BEARING CELLS AND PREVENTS HIV-1 INFECTION
    SHAPIRANAHOR, O
    GOLDING, H
    VUJCIC, LK
    RESTORUIZ, S
    FIELDS, RL
    ROBEY, FA
    CELLULAR IMMUNOLOGY, 1990, 128 (01) : 101 - 117
  • [6] HIV-1 GP120 RECEPTOR ON CD4-NEGATIVE BRAIN-CELLS ACTIVATES A TYROSINE KINASE
    HECKER, C
    SCHNEIDERSCHAULIES, J
    SCHNEIDERSCHAULIES, S
    BRINKMANN, R
    TAS, P
    HALBRUGGE, M
    WALTER, U
    HOLMES, HC
    TERMEULEN, V
    JOURNAL OF CELLULAR BIOCHEMISTRY, 1993, : 30 - 30
  • [7] HIV-1 GP120 RECEPTOR ON CD4-NEGATIVE BRAIN-CELLS ACTIVATES A TYROSINE KINASE
    SCHNEIDERSCHAULIES, J
    SCHNEIDERSCHAULIES, S
    BRINKMANN, R
    TAS, P
    HALBRUGGE, M
    WALTER, U
    HOLMES, HC
    TERMEULEN, V
    VIROLOGY, 1992, 191 (02) : 765 - 772
  • [8] BINDING OF SOLUBLE CD4 TO GP120 PROMOTES BINDING OF HIV-1 VIRIONS TO CD4-NEGATIVE CELLS
    DEMARIA, S
    BUSHKIN, Y
    JOURNAL OF CELLULAR BIOCHEMISTRY, 1995, : 218 - 218
  • [9] SURAMIN INHIBITS BINDING OF THE V3 REGION OF HIV-1 ENVELOPE GLYCOPROTEIN GP120 TO GALACTOSYLCERAMIDE, THE RECEPTOR FOR HIV-1 GP120 ON HUMAN COLON EPITHELIAL-CELLS
    YAHI, N
    SABATIER, JM
    NICKEL, P
    MABROUK, K
    GONZALEZSCARANO, F
    FANTINI, J
    JOURNAL OF BIOLOGICAL CHEMISTRY, 1994, 269 (39) : 24349 - 24353
  • [10] Electrostatic modeling of peptides derived from the V3-loop of HIV-1 gp120: Implications of the interaction with chemokine receptor CCR5
    Morikis, Dimitrios
    Rizos, Apostolos K.
    Spandidos, Demetrios A.
    Krambovitis, Elias
    INTERNATIONAL JOURNAL OF MOLECULAR MEDICINE, 2007, 19 (03) : 343 - 351
12345